Clear Scientific: Combatting the Opioid Epidemic
Vital Science
English - March 26, 2024 12:00 - 32 minutes - 45.4 MB - ★★★★★ - 22 ratingsLife Sciences Science Technology life sciences biotech pharma cro drug development Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Opioid use in the United States has exploded into a nationwide crisis.
Users who want to get clean and rid themselves of methamphetamine, cocaine, and/or fentanyl often find it difficult, essentially “chaining” themselves into a cycle of drug use that’s mostly impossible to break. However, what if there was a drug that could eliminate toxins and restore normal bodily function within minutes?
That’s the aim of Clear Scientific, a small biotech in Cambridge, MA that’s currently testing a treatment (CS-1103) using small molecules to “eat” toxins and deactivate their harmful effects almost instantly. With Phase I of a first-in-human (FIH) clinical trial ongoing, this revolutionary therapeutic is offering hope to those suffering from drug misuse and addiction a “chance to get better.”
Join us as Mitch Zakin, Executive Vice President of Innovation, and Winston Henderson, Co-founder and General Counsel, discuss their therapeutic approach, offer an update on their progress with CS-1103, how collaboration has enhanced their development, and how they hope it will eventually impact the opioid epidemic.
Show Notes
World Congress: Drug Modality Game Changers
Clear Scientific to Start Phase 1 Trial for Stimulant Antidote